Leukemia
Showing 7726 - 7750 of 9,158
Leukemia Trial in United States (daunorubicin HCl, imatinib mesylate, prednisone)
Completed
- Leukemia
- daunorubicin hydrochloride
- +3 more
-
Duarte, California
- +4 more
Jun 20, 2013
Leukemia Trial in United Kingdom (rituximab, cyclophosphamide, fludarabine phosphate)
Completed
- Leukemia
- rituximab
- +3 more
-
Birmingham, England, United Kingdom
- +15 more
Aug 1, 2013
Leukemia Trial in New York (arsenic trioxide)
Completed
- Leukemia
- arsenic trioxide
-
New York, New YorkMemorial Sloan-Kettering Cancer Center
Jun 20, 2013
Chronic Myeloproliferative Disorders, Kidney Cancer, Leukemia Trial in Milwaukee (management of therapy complications, pain
Unknown status
- Chronic Myeloproliferative Disorders
- +11 more
- management of therapy complications
- pain therapy
-
Milwaukee, WisconsinMedical College of Wisconsin Cancer Center
Sep 19, 2013
Acute Myelogenous Leukemia, MDS, Chronic Myelogenous Leukemia Trial in Dallas (Clofarabine and Cytarabine)
Completed
- Acute Myelogenous Leukemia
- +2 more
- Clofarabine and Cytarabine
-
Dallas, TexasBaylor University Medical Center
Jul 15, 2013
Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, Acute Myelogenous Leukemia Trial in United States (VCL-CB01,
Completed
- Acute Lymphoblastic Leukemia
- +5 more
- VCL-CB01
- Phosphate-buffered Saline (PBS)
-
Tucson, Arizona
- +21 more
Jul 31, 2013
Allografted With Myeloablative Conditioning Trial in Paris (Serum concentration /Serum inflammatory)
Completed
- Allografted With Myeloablative Conditioning
- Serum concentration /Serum inflammatory
-
Paris, France
- +2 more
Apr 9, 2015
Thiopurine Methyltransferase Activity on Toxicity After
Completed
- Acute Lymphoblastic Leukemia
-
Copenhagen, DenmarkKjeld Schmiegelow
Jun 21, 2013
Leukemia, Lymphoma Trial in New York (filgrastim, rituximab, cyclophosphamide)
Completed
- Leukemia
- Lymphoma
- filgrastim
- +3 more
-
New York, New YorkMemorial Sloan-Kettering Cancer Center
Jun 24, 2013
Leukemia Trial in New York (biological, drug, procedure, radiation)
Completed
- Leukemia
- recombinant interferon alfa
- +8 more
-
New York, New YorkMemorial Sloan-Kettering Cancer Center
Jun 24, 2013
Leukemia Trial in New York (lintuzumab, cytarabine, idarubicin)
Completed
- Leukemia
- lintuzumab
- +2 more
-
New York, New YorkMemorial Sloan-Kettering Cancer Center
Jun 20, 2013
Leukemia Trial in Worldwide (biological, drug, procedure, radiation)
Unknown status
- Leukemia
- filgrastim
- +10 more
-
Brno, Czech Republic
- +187 more
Dec 17, 2013
Leukemia, Lymphoma Trial in United States (dolastatin 10)
Completed
- Leukemia
- Lymphoma
- dolastatin 10
-
Baltimore, Maryland
- +3 more
Jun 25, 2013
Non-Hodgkins Lymphoma, Hodgkin's Disease, Acute Lymphoblastic Leukemia Trial in San Diego, Memphis (Dexamethasone, Irinotecan,
Completed
- Non-Hodgkins Lymphoma
- +2 more
- Dexamethasone
- +2 more
-
San Diego, California
- +1 more
Aug 26, 2013
Recurrent Small Cell Lung Cancer Trial in Rochester (imatinib mesylate, laboratory biomarker analysis)
Completed
- Recurrent Small Cell Lung Cancer
- imatinib mesylate
- laboratory biomarker analysis
-
Rochester, MinnesotaNorth Central Cancer Treatment Group
Oct 7, 2013
Leukemia, MDS, Neutropenia Trial in New York (filgrastim, lintuzumab, cytarabine)
Completed
- Leukemia
- +2 more
- filgrastim
- +4 more
-
New York, New YorkMemorial Sloan-Kettering Cancer Center
Jul 1, 2013
Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia Trial in Ann Arbor (TAK-901)
Completed
- Acute Myeloid Leukemia
- +11 more
-
Ann Arbor, MichiganUniversity of Michigan
Jul 1, 2013
Acute Myeloid Leukemia Trial in Dresden (Conditioning therapy)
Terminated
- Acute Myeloid Leukemia
- Conditioning therapy
-
Dresden, GermanyMedizinische Klinik und Poliklinik I
Jun 19, 2013
Anemia, Leukemia, Neutropenia Trial in New York (filgrastim, leridistim, cytarabine)
Completed
- Anemia
- +3 more
- filgrastim
- +3 more
-
New York, New YorkMemorial Sloan-Kettering Cancer Center
Jun 18, 2013
MALT, Nodal Marginal Zone B-cell Lymphoma, Noncontiguous Stage II Marginal Zone Lymphoma Trial in Columbus (apolizumab,
Completed
- Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue
- +13 more
- apolizumab
- +2 more
-
Columbus, OhioOhio State University Medical Center
Jun 3, 2013
Leukemia Trial in New York (arsenic trioxide, imatinib mesylate)
Completed
- Leukemia
- arsenic trioxide
- imatinib mesylate
-
New York, New YorkMemorial Sloan-Kettering Cancer Center
Jun 4, 2013